HIMS Trading Analysis - 10/16/2026 10:58 AM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and contextual items relevant to HIMS & Hers (HIMS) include:

• HIMS reported strong Q2 2026 subscriber growth in telehealth and GLP-1 related offerings, continuing to diversify beyond weight-loss medications.
• The company faced regulatory scrutiny from the FDA over compounded semaglutide offerings, creating periodic volatility spikes.
• Analysts have noted rising competition in direct-to-consumer telehealth, pressuring margins despite top-line expansion.
• No confirmed near-term earnings date in provided data; next major options expiration is 2026-11-20 per chain.
• Context: Headlines around growth and regulation align with high beta (4.22) and elevated historical volatility (57.75%) seen in fundamentals, while options flow shows bullish conviction despite fundamental net loss.

Fundamental Analysis

Based strictly on embedded FUNDAMENTALS data for HIMS (as of 2026-10-16):

• Trailing P/E: 51.10; Trailing EPS: -0.62 (negative earnings, net loss per share).
• PEG Ratio: null; Forward P/E: null; Revenue Growth: null; Profit Margins: null (not provided).
• Market Cap: $6,848,366,495.10; Shares Outstanding: 233,313,000.00; Dividend Yield: 0.00.
• Beta: 4.22 (very high systematic risk); 52-Week Range: $13.74 to $63.63 (current ~$29.28 near lower-middle).
• Institutional Ownership: 42.41%; Average Volume: 10,819,000.00; Historical Volatility: 57.75%.
• Debt/Equity, ROE, Free Cash Flow: null (unavailable); Recommendation Key: null; Target Mean Price: null.
• Fundamentals show negative EPS with rich P/E (due to losses, ratio distorted) and no analyst target. This diverges from bullish options sentiment and near-flat technicals, suggesting speculative positioning rather than fundamental support.

Current Market Position

Current price per indicators: $29.28 (2026-10-15 close). Minute bars show 2026-10-15 open $26.88, low $26.33, high $29.65, close $29.28 on volume 12,908,956. On 2026-10-16 up to 10:30, price traded $29.13 to $29.48, last $29.35, indicating recovery from prior day low and intraday stability above $29.00.

Key levels from data: 30-day low $26.33, 30-day high $31.81; Bollinger lower $27.53, middle $29.29, upper $31.05. Price sits at middle band.

Technical Analysis

SMA alignment: SMA 5 (29.67) > SMA 50 (29.37) > SMA 20 (29.29), slight bearish tilt as 5-day above 50/20 but price at 29.28 below SMA 5. No golden/death cross active. RSI 49.38 neutral momentum. MACD 0.05 above signal 0.04, histogram 0.01 bullish micro-crossover. Bollinger mid 29.29, price 29.28 at midline, no squeeze (band width 3.52). 30-day range: low 26.33, high 31.81; price at 38.2% of range. ATR 1.88 shows daily swing capacity.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-16 10:58) shows Bullish sentiment. Call dollar volume $646,740.00 (62.1%) vs Put $394,110.00 (37.9%); total $1,040,850.00. Call contracts 2,840, put 2,270; call trades 42 vs 20. Pure directional conviction favors calls. This aligns with MACD bullish crossover but diverges from neutral RSI and negative EPS fundamentals.

Call Volume: $646,740.00 (62.1%) Put Volume: $394,110.00 (37.9%) Total: $1,040,850.00